Example: Heart Attack

Search clinical trials for: Plasminogen Activator Inhibitor 1

Total 40 results

NCT00515021

Completed

Diurnal Variation of Plasminogen Activator Inhibitor-1

Conditions: Metabolic Syndrome X
NCT01211899

Unknown status

4G/5G Polymorphism of Plasminogen Activator Inhibitor-1 Gene and Disseminated Intravascular Coagulation in Severe Sepsis and Septic Shock

Conditions: Severe Sepsis
NCT02815176

Unknown status

Angiographic Characteristics of CSC, PCV Patients and Thrombotic Bio-markers

Conditions: Central Serous Chorioretinopathy; Polypoidal Choroidal Vasculopathy
NCT00770328

Completed

The Effects of Pentoxifylline on PAI-1 in an Obese Population

Conditions: Obesity
NCT03803176

Completed

Tissue Plasminogen Activator & Plasminogen Activator Inhibitor Type-1 In Gingival Tissues Of Chronic Periodontitis

Conditions: Chronic Periodontitis
NCT00159952

Completed

Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic Shock

Conditions: Severe Sepsis; Septic Shock
NCT03733223

Recruiting

Relationships Among FVIII, t-PA/PAI-1, and MMP-9 Levels and Intracranial Hemorrhage Complications After Thrombolysis With Alteplase in Patients With Acute Ischemic Stroke: Protocol for a Multicenter Retrospective Study

Conditions: Ischemic Stroke
NCT02548689

Enrolling by invitation

PAI-1 Expression in Non-scarring Hair Loss

Conditions: Androgenetic Alopecia; Telogen Effluvium; Alopecia Areata
NCT00512031

Terminated

Characterizing PAI-1 Modulation on Monocyte Adhesion

Conditions: Atherosclerosis
NCT01592825

Active, not recruiting

PiA: Prognosis Used Every Day for Patients With Operable Breast Cancer - Comparison of Invasion Factors uPA/PAI-1 With Other Prognostic Factors

Conditions: Breast Cancer
NCT04305171

Completed

Effect of Non-surgical Periodontal Treatment on Cardiovascular Risk Markers

Conditions: Coronary Heart Disease; Periodontitis
NCT01317108

Completed

Prognostic and Predictive Impact of uPA/PAI-1

Conditions: Breast Cancer
NCT00007410

Completed

Genetic Architecture of Plasma T-PA and PAI-1

Conditions: Cardiovascular Diseases; Heart Diseases; Thrombosis; Atherosclerosis
NCT00512603

Completed

Association Between Levels of D-Dimer, Fibrinogen and PAI-1 in Elderly Patients With Infection and Occurrence of Cardio- and Cerebro-vascular Disease After Discharge

Conditions: Infection; Acute Coronary Syndrome; Cerebrovascular Disease
NCT01456208

Active, not recruiting

Genetic Mechanisms in Human Hypertension

Conditions: Hypertension
NCT00512369

Terminated

Effects of PA-1 Transcriptional Regulation on Monocyte Function

Conditions: Atherosclerosis
NCT01206712

Completed

Beta Cell Relieving and Cardiovascular Protective Effects of LANTUS Treatment in Type 2 Diabetes Patients

Conditions: Diabetes Mellitus, Type 2
NCT01957774

Completed

THR-18's Pharmacokinetics and Pharmacodynamics in Subjects With Acute Ischemic Stroke Treated With tPA

Conditions: Stroke, Acute
NCT00385931

Completed

Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin

Conditions: Hypertension; Hypercholesterolemia; Dyslipidemia
NCT03347591

Recruiting

Rare Bleeding Disorders in the Netherlands

Conditions: Rare Bleeding Disorders
NCT03903302

Completed

Study Investigation Pharmacokinetics and Pharmacodynamics of CS1

Conditions: Thrombosis
NCT02572336

Unknown status

A Study of the Safety, Imaging and Clinical Outcomes of THR-18 in Acute Stroke Subjects Treated With tPA

Conditions: Ischemic Stroke
NCT04366778

Recruiting

Thrombosis and Covid-19

Conditions: Thrombosis; Covid-19; SARS-CoV 2
NCT00608465

Terminated

Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity

Conditions: Metabolic Syndrome X
NCT01096693

Suspended

Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 2)

Conditions: Vascular Disease; Heart Disease